United Therapeutics
UTHR
UTHR
619 hedge funds and large institutions have $15.4B invested in United Therapeutics in 2024 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 204 increasing their positions, 223 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
619
Holders Change
+57
Holders Change %
+10.14%
% of All Funds
8.95%
Holding in Top 10
17
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-5.56%
% of All Funds
0.25%
New
111
Increased
204
Reduced
223
Closed
49
Calls
$74.3M
Puts
$110M
Net Calls
-$35.4M
Net Calls Change
-$37.1M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$113M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$89M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$72.7M |
| 4 |
HSBC Holdings
London,
United Kingdom
|
+$58.1M |
| 5 |
AssetMark Inc
Concord,
California
|
+$54.6M |
Top Sellers
| 1 |
Citigroup
New York
|
-$530M |
| 2 |
Morgan Stanley
New York
|
-$145M |
| 3 |
Amundi
Paris,
France
|
-$145M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$68.3M |
| 5 |
BlackRock
New York
|
-$54.3M |
